Operations

SVP of advanced analytics Pravin Pant and associate VP of interoperability strategy Michael Gould, both at ZeOmega, discuss how providers should adopt FHIR standards to achieve TEFCA compliance and enable easier data sharing with payers.  

Aytan Dahukey, partner and private equity team leader, and healthcare team member at Sheppard Mullin, says that growth areas in private equity are opportunistic and discusses some challenges ahead.  

Dr. Lyle Berkowitz, CEO of KeyCare, discusses the coordinated care company's partnerships with healthcare systems using Epic and how it efficiently coordinates virtual care delivery for urgent care, primary care and beyond using technology.  

Jesus Diaz, director, nursing informatics at Memorial Healthcare System, tells the story of a mother who used the health system's mobile app to monitor her premature twins' NICU progress. It reduced her anxiety when she couldn't be there.  

In part two of a two-part series, Dr. Bruce Darrow, CMIO and interim CDIO at Mount Sinai Health System, discusses how the health system utilizes AI for predictive care, reading diagnostic images, and streamlining administrative operations.  

Dr. Harm Scherpbier, HealthShare Exchange CMIO, describes how the company's platform connects practices, payers and ACOs, allowing them to share patients’ data in real time across facilities to coordinate care seamlessly.  

Ran Balicer, HIMSS board of directors member, talks about the possibility of clinical digital support technology to personalize care by helping clinicians predict potential health issues for patients so they can be prevented.  

In part one of a two-part series, Dr. Bruce Darrow, Mount Sinai Health System CMIO and interim CDIO, relays how patients may gain confidence in relying on AI instead of doctors as accuracy of pattern recognition and predictive models improve.  

Aaron Gani, CEO and founder of RealizedCare, discusses the evolution of digital therapeutics, the FDA’s place in advancing them, keeping up with evolving technology, and the benefits of DTx modalities for the pharmaceutical industry.  

Andy Molnar, CEO of the Digital Therapeutics Alliance, discusses the definition of a digital therapeutic, companies in the DTx space, why the organization held its recent summit in D.C. and the status of the Prescription Digital Therapeutics Act.